Precigen Reports Fourth Quarter and Full Year 2020 Financial Results

Go back to Precigen Reports Fourth Quarter and Full Year 2020 Financial Results

Precigen Inc. (PGEN) Misses Q4 EPS by 7c, Revenues Miss

March 1, 2021 4:20 PM EST

Precigen Inc. (NASDAQ: PGEN) reported Q4 EPS of ($0.22), $0.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $19.33 million versus the consensus estimate of $21.2 million.

"2021 promises to be another transformative year for our company with important data readouts and trial... More